title: Sleep electroencephalogram delta-frequency amplitude, night plasma levels of tumor necrosis factor alpha, and human immunodeficiency virus infection.
abstract: We tested the hypothesis that increases in tumor necrosis factor alpha (TNF-alpha) induced by human immunodeficiency virus (HIV) are associated with the increases in slow-wave sleep seen in early HIV infection and the decrease with sleep fragmentation seen in advanced HIV infection. Nocturnal sleep disturbances and associated fatigue contribute to the disability of HIV infection. TNF-alpha causes fatigue in clinical use and promotes slow-wave sleep in animal models. With slow progress toward a vaccine and weak effects from current therapies, efforts are directed toward extending productive life of HIV-infected individuals and shortening the duration of disability in terminal illness. We describe previously unrecognized nocturnal cyclic variations in plasma levels of TNF-alpha in all subjects. In 6 of 10 subjects (1 control subject, 3 HIV-seropositive patients with CD4+ cell number > 400 cells per microliters, and 2 HIV-positive patients with CD4+ cell number < 400 cells per microliters), these fluctuations in TNF-alpha were coupled to the known rhythm of electroencephalogram delta amplitude (square root of power) during sleep. This coupling was not present in 3 HIV-positive subjects with CD4+ cell number < 400 cells per microliters and 1 control subject. In 5 HIV subjects with abnormally low CD4+ cell counts ( < 400 cells per microliters), the number of days since seroconversion correlated significantly with low correlation between TNF-alpha and delta amplitude. We conclude that a previously unrecognized normal, physiological coupling exists between TNF-alpha and delta amplitude during sleep and that the lessened likelihood of this coupling in progressive HIV infection may be important in understanding fatigue-related symptoms and disabilities.
authors.affiliation: Department of Neuropharmacology, Scripps Research Institute, La Jolla, CA 92037, USA.
authors.forename: D F
authors.initials: DF
authors.lastname: Darko
authors.forename: J C
authors.initials: JC
authors.lastname: Miller
authors.forename: C
authors.initials: C
authors.lastname: Gallen
authors.forename: J
authors.initials: J
authors.lastname: White
authors.forename: J
authors.initials: J
authors.lastname: Koziol
authors.forename: S J
authors.initials: SJ
authors.lastname: Brown
authors.forename: R
authors.initials: R
authors.lastname: Hayduk
authors.forename: J H
authors.initials: JH
authors.lastname: Atkinson
authors.forename: J
authors.initials: J
authors.lastname: Assmus
authors.forename: D T
authors.initials: DT
authors.lastname: Munnell
authors.forename: P
authors.initials: P
authors.lastname: Naitoh
authors.forename: J A
authors.initials: JA
authors.lastname: McCutchan
authors.forename: M M
authors.initials: MM
authors.lastname: Mitler
mesh_terms: D000328:Adult; D000818:Animals; D003700:Delta Rhythm; D018023:HIV Seronegativity / Q000276:immunology / Q000502:physiology*; D006679:HIV Seropositivity / Q000097:blood / Q000276:immunology / Q000503:physiopathology*; D006801:Humans; D008297:Male; D012016:Reference Values; D012890:Sleep / Q000276:immunology / Q000502:physiology*; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis / Q000378:metabolism* / Q000633:toxicity
chemical_list: D014409:Tumor Necrosis Factor-alpha